Nurix Therapeutics NRIX
NASDAQ NRIX
$16.32 +0.44 (+2.77%)
As of: Nov 11, 2026 · 3:59 PM EST

Nurix Therapeutics (NRIX) EBT Margin (2019 - 2026)

Updated

Nurix Therapeutics' EBT Margin was 83.71% in fiscal Q3 2026 (quarter ended Aug 31, 2026), up 1178.48 percentage points from -1094.77% a year earlier and up 1076.81 percentage points from the prior quarter.

Analysis

Nurix Therapeutics (NRIX) EBT Margin (2019 - 2026) Analysis & Trends

On a trailing twelve-month basis, Nurix Therapeutics' EBT Margin was 43.91% through Aug 31, 2026, up 335.49 percentage points year-over-year; for FY2025 (ended Nov 30, 2025), it came in at -314.00%, up 40.36 percentage points from FY2024.

  • EBT Margin shows a five-year change of +43.90 percentage points (FY2020 to FY2025).
  • In earlier fiscal years, EBT Margin was -354.36% in FY2024 (-167.38 pp), -186.98% in FY2023 (+279.95 pp), -466.93% in FY2022 (-73.44 pp) and -393.49% in FY2021 (-35.59 pp).
  • The fiscal Q3 2026 figure marks the highest quarterly EBT Margin in data going back to fiscal Q3 2019.
  • Compared with a year earlier, EBT Margin was higher in two of the last eight quarters, with an average year-over-year change of -199.67 percentage points.
  • The best year-over-year quarter for EBT Margin over five years was fiscal Q3 2026 (a gain of 1178.48 percentage points); the worst was fiscal Q1 2026 (a drop of 1088.96 percentage points).
  • Per Business Quant data, NRIX's EBT Margin in the three fiscal quarters before Q3 2026 was -993.10% (Q2 2026), -1394.34% (Q1 2026) and -576.13% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 0.13%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 27.75%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.74%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 26.27%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 45.21%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 36.90%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 20.41%
10 Nurix Therapeutics 1.73 Bn -891.35 Mn - 83.71%
Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2026 83.71%
May 31, 2026 -993.10%
Feb 28, 2026 -1,394.34%
Nov 30, 2025 -576.13%
Aug 31, 2025 -1,094.77%
May 31, 2025 -96.93%
Feb 28, 2025 -305.38%
Nov 30, 2024 -440.69%
Aug 31, 2024 -388.26%
May 31, 2024 -367.65%
Feb 29, 2024 -249.79%
Nov 30, 2023 -276.77%
Aug 31, 2023 -200.26%
May 31, 2023 -79.14%
Feb 28, 2023 -321.11%
Nov 30, 2022 -688.74%
Aug 31, 2022 -423.58%
May 31, 2022 -397.14%
Feb 28, 2022 -442.09%
Nov 30, 2021 -509.17%
API Access

Nurix Therapeutics EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=NRIX&period=max&api_key=YOUR_API_KEY